(Q48201200)

9 February 2018

title

Blood-brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons. (English)

1 reference

9 February 2018

1 reference

1 reference

Inmaculada Rite

1

1 reference

9 February 2018

Alberto Machado

series ordinal

2

1 reference

9 February 2018

Josefina Cano

series ordinal

3

1 reference

9 February 2018

José L Venero

series ordinal

4

1 reference

9 February 2018

language of work or name

English

0 references

publication date

16 April 2007

1 reference

9 February 2018

Journal of Neurochemistry

published in

1 reference

9 February 2018

volume

101

1 reference

9 February 2018

issue

6

1 reference

9 February 2018

page(s)

1567-1582

1 reference

9 February 2018

cites work

Ischaemic brain oedema

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Head trauma preceding PD: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Vascular endothelial growth factor and the nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Thrombin induces in vivo degeneration of nigral dopaminergic neurones along with the activation of microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

6-Hydroxydopamine-induced alterations in blood-brain barrier permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Regional variation in brain capillary density and vascular response to ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

VEGF-mediated inflammation precedes angiogenesis in adult brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Two genes encode distinct glutamate decarboxylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Risperidone-induced tardive dystonia and psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

The glial scar and central nervous system repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

VEGF: an update on biological and therapeutic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Vascular parkinsonism: a review of the precision and frequency of the diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Oxidative stress and inflammation in Parkinson's disease: is there a causal link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Intraventricular infusion of vascular endothelial growth factor promotes cerebral angiogenesis with minimal brain edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

In situ hybridization analysis of chemokines and chemokine receptors in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Neuronal vascular relationships in the zona compacta of normal and parkinsonian substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Blood-brain barrier dysfunction in parkinsonian midbrain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Microglia: a sensor for pathological events in the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Turnover of resident microglia in the normal adult mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Apoptosis in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

The blood-brain barrier and cerebral angiogenesis: lessons from the cold-injury model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Pathophysiology of the basal ganglia in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Angiogenic and neurotrophic effects of vascular endothelial growth factor (VEGF165): studies of grafted and cultured embryonic ventral mesencephalic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

A one-step immunohistochemical method for detection of blood-brain barrier disturbances for immunoglobulins in lesioned rat brain with special reference to false-positive labelling in immunohistochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Caspases, IAPs and Smac/DIABLO: mechanisms from structural biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Response of endogenous glial cells to motor neuron degeneration induced by toxic ricin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Importance of aquaporins in the physiopathology of brain edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Pathophysiological consequences of VEGF-induced vascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Brain injury and neurologic sequelae: a cohort study of dementia, parkinsonism, and amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Neuroprotective effects of vascular endothelial growth factor (VEGF) upon dopaminergic neurons in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

Neurorescue effects of VEGF on a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

The differences between high and low-dose administration of VEGF to dopaminergic neurons of in vitro and in vivo Parkinson's disease model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04567.X

10.1111/J.1471-4159.2007.04567.X

21 January 2018

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

17437543

1 reference

9 February 2018